1. Home
  2. NEOV vs STIM Comparison

NEOV vs STIM Comparison

Compare NEOV & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeoVolta Inc.

NEOV

NeoVolta Inc.

HOLD

Current Price

$2.17

Market Cap

127.5M

Sector

Miscellaneous

ML Signal

HOLD

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$2.11

Market Cap

120.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEOV
STIM
Founded
2018
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
127.5M
120.4M
IPO Year
2022
2018

Fundamental Metrics

Financial Performance
Metric
NEOV
STIM
Price
$2.17
$2.11
Analyst Decision
Buy
Strong Buy
Analyst Count
4
4
Target Price
★ $9.75
$5.75
AVG Volume (30 Days)
★ 1.3M
685.0K
Earning Date
11-09-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 57.25
EPS
N/A
★ N/A
Revenue
$13,332,953.00
★ $52,776,000.00
Revenue This Year
$623.96
$8.63
Revenue Next Year
$344.27
$9.24
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 58.22
N/A
52 Week Low
$1.36
$0.80
52 Week High
$7.13
$3.44

Technical Indicators

Market Signals
Indicator
NEOV
STIM
Relative Strength Index (RSI) 38.29 41.69
Support Level $2.03 $1.99
Resistance Level $3.21 $2.13
Average True Range (ATR) 0.18 0.10
MACD -0.02 0.02
Stochastic Oscillator 12.56 60.23

Price Performance

Historical Comparison
NEOV
STIM

About NEOV NeoVolta Inc.

NeoVolta Inc is engaged in designing, manufacturing, and selling high-end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its marketplace includes the solar industry, installers, new construction homebuilders, home remodelers, and homeowners. Its ESS product portfolio includes the NV14, NV24, NVPlus, NV7600 stand-alone inverter, and the NV16 kW AC hybrid inverter with 24 kW PV input and a 250 kW / 430 kWh C&I system.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Share on Social Networks: